We are live on ! Find out more
CC

Capital Counsel Portfolio holdings

AUM $2.35B
1-Year Est. Return 21.34%
This Fund
S&P 500
This Quarter Est. Return
+10.97%
1 Year Est. Return
+21.34%
3 Year Est. Return
+69.88%
5 Year Est. Return
+102.01%
10 Year Est. Return
+473.12%
AUM
$1.59B
AUM Growth
+$44.2M
Cap. Flow
-$87M
Cap. Flow %
-5.48%
Top 10 Hldgs %
92.61%
Holding
52
New
–
Increased
17
Reduced
11
Closed
–

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$6.36M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.33M
3
ANET icon
Arista Networks
ANET
+$2.62M
4
MSFT icon
Microsoft
MSFT
+$2.25M
5
V icon
Visa
V
+$1.56M

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$63.6M
2
QCOM icon
Qualcomm
QCOM
+$37.3M
3
MTD icon
Mettler-Toledo International
MTD
+$3.25M
4
HD icon
Home Depot
HD
+$869K
5
ADP icon
Automatic Data Processing
ADP
+$674K

Sector Composition

Rank Sector Weight
1 Healthcare 29.18%
2 Technology 24.98%
3 Financials 19.42%
4 Consumer Staples 10.64%
5 Communication Services 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRNA icon
26
Moderna
MRNA
$21.8B
$1.4M 0.09%
7,768
+21
+0.3% +$3.43K
GOOGL icon
27
Alphabet (Google) Class A
GOOGL
$4.36T
$1.35M 0.08%
15,275
+160
+1% +$15.2K
KGC icon
28
Kinross Gold
KGC
$27.4B
$1.32M 0.08%
322,042
– –
SIRI icon
29
SiriusXM
SIRI
$9.98B
$1.17M 0.07%
20,000
– –
FTV icon
30
Fortive
FTV
$17.9B
$979K 0.06%
20,212
– –
WAB icon
31
Wabtec
WAB
$49.1B
$818K 0.05%
8,200
– –
SPY icon
32
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$769K 0.05%
2,010
– –
RETA
33
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$646K 0.04%
17,000
– –
WMT icon
34
Walmart Inc
WMT
$885B
$485K 0.03%
10,257
+432
+4% +$20.5K
TMO icon
35
Thermo Fisher Scientific
TMO
$213B
$457K 0.03%
830
-20
-2% -$10.6K
CHRW icon
36
C.H. Robinson
CHRW
$17.4B
$449K 0.03%
4,900
– –
IBM icon
37
IBM
IBM
$211B
$444K 0.03%
3,148
– –
FIS icon
38
Fidelity National Information Services
FIS
$23.1B
$439K 0.03%
6,475
-200
-3% -$14.2K
AMGN icon
39
Amgen
AMGN
$208B
$427K 0.03%
1,625
– –
VOO icon
40
Vanguard S&P 500 ETF
VOO
$979B
$422K 0.03%
1,200
– –
SM icon
41
SM Energy
SM
$7.8B
$415K 0.03%
11,905
-1,115
-9% -$46.4K
EW icon
42
Edwards Lifesciences
EW
$49.6B
$407K 0.03%
5,450
-825,854
-99% -$63.6M
JPM icon
43
JPMorgan Chase
JPM
$935B
$364K 0.02%
2,714
+400
+17% +$50.7K
FLO icon
44
Flowers Foods
FLO
$1.49B
$334K 0.02%
11,610
– –
ADBE icon
45
Adobe
ADBE
$99.5B
$303K 0.02%
900
– –
PG icon
46
Procter & Gamble
PG
$336B
$277K 0.02%
1,827
+107
+6% +$15K
NRGV icon
47
Energy Vault
NRGV
$517M
$255K 0.02%
81,725
– –
NSC icon
48
Norfolk Southern
NSC
$75.4B
$244K 0.02%
990
– –
VFC icon
49
VF Corp
VFC
$5.63B
$241K 0.02%
8,721
– –
GLW icon
50
Corning
GLW
$119B
$240K 0.02%
7,500
– –
1
2
3

Similar funds

HFM
Harvest Fund Management Beijing, China $2.35B AUM 49.85% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return
G
GenTrust Miami, Florida $2.34B AUM 18.43% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
BAM
Berkshire Asset Management Wilkes Barre, Pennsylvania $2.33B AUM 19.33% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return

Capital Counsel's Q4 2022 Portfolio in Review

As of Q4 2022, Capital Counsel held 52 positions worth $1.59B, up 2.9% from $1.55B the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Capital Counsel withdrew a net $87M in Q4 2022, reducing 11 holdings. Its largest reduction was Edwards Lifesciences, cutting an estimated $63.6M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 28% a quarter earlier, followed by Technology and Financials.

Against the trend, Capital Counsel added an estimated $6.36M to CME Group.

  • Capital Counsel added most to CME Group in Q4 2022, an estimated $6.36M increase.
  • Capital Counsel's biggest Q4 2022 reduction was Edwards Lifesciences, cutting an estimated $63.6M.
  • Capital Counsel's ten largest holdings make up 93% of its $1.59B portfolio in Q4 2022.
  • Capital Counsel opened 0 new positions and closed 0 in Q4 2022.
  • Capital Counsel's portfolio value rose 2.9% quarter-over-quarter to $1.59B.

Based on Capital Counsel's 13F filing for Q4 2022, filed 9 Feb 2023.